{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:12:42Z","timestamp":1787886762596,"version":"build-2784847793"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003510","name":"Estonian Ministry of Education and Research","doi-asserted-by":"crossref","award":["IUT20-46"],"award-info":[{"award-number":["IUT20-46"]}],"id":[{"id":"10.13039\/501100003510","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Osteogenesis imperfecta (OI) is a rare genetic disorder in which the patients suffer from numerous fractures, skeletal deformities and bluish sclera. The disorder ranges from a mild form to severe and lethal cases. The main objective of this pilot study was to compare the blood transcriptional landscape of OI patients with <jats:italic>COL1A1<\/jats:italic> pathogenic variants and their healthy relatives, in order to find out different gene expression and dysregulated molecular pathways in OI.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We performed RNA sequencing analysis of whole blood in seven individuals affected with different OI severity and their five unaffected relatives from the three families. The data was analyzed using edgeR package of R Bioconductor. Functional profiling and pathway analysis of the identified differently expressed genes was performed with g:GOSt and MinePath web-based tools.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>We identified 114 differently expressed genes. The expression of 79 genes was up-regulated, while 35 genes were down-regulated. The functional analysis identified a presence of dysregulated interferon signaling pathways (<jats:italic>IFI27, IFITM3, RSAD12, GBP7<\/jats:italic>). Additionally, the expressions of the genes related to extracellular matrix organization, Wnt signaling, vitamin D metabolism and MAPK-ERK 1\/2 pathways were also altered.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The current pilot study successfully captured the differential expression of inflammation and bone metabolism pathways in OI patients. This work can contribute to future research of transcriptional bloodomics in OI. Transcriptional bloodomics has a strong potential to become a major contributor to the understanding of OI pathological mechanisms, the discovery of phenotype modifying factors, and the identification of new therapeutic targets. However, further studies in bigger cohorts of OI patients are needed to confirm the findings of the current work.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12920-020-00825-7","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T20:03:53Z","timestamp":1606161833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["RNA sequencing analysis reveals increased expression of interferon signaling genes and dysregulation of bone metabolism affecting pathways in the whole blood of patients with osteogenesis imperfecta"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4682-0402","authenticated-orcid":false,"given":"Lidiia","family":"Zhytnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katre","family":"Maasalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ene","family":"Reimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aare","family":"M\u00e4rtson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulev","family":"K\u00f5ks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"key":"825_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev.me.43.020192.001413","volume":"43","author":"PH Byers","year":"1992","unstructured":"Byers PH, Steiner RD. Osteogenesis imperfecta. Annu Rev Med. 1992;43:269\u201382. https:\/\/doi.org\/10.1146\/annurev.me.43.020192.001413.","journal-title":"Annu Rev Med"},{"key":"825_CR2","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","volume":"164A","author":"FS Van Dijk","year":"2014","unstructured":"Van Dijk FS, Sillence DO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A. 2014;164A:1470\u201381.","journal-title":"Am J Med Genet A"},{"key":"825_CR3","doi-asserted-by":"crossref","unstructured":"Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16:101\u201316. http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=1012733&tool=pmcentrez&rendertype=abstract. Accessed 18 Sep 2014.","DOI":"10.1136\/jmg.16.2.101"},{"key":"825_CR4","doi-asserted-by":"publisher","unstructured":"Zhytnik L, Maasalu K, Reimand T, Duy BH, K\u00f5ks S, M\u00e4rtson A. Inter- and intrafamilial phenotypic variability in individuals with collagen-related Osteogenesis Imperfecta. Clin Transl Sci. 2020;:cts.12783. doi:https:\/\/doi.org\/10.1111\/cts.12783.","DOI":"10.1111\/cts.12783"},{"key":"825_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/humu.20429","volume":"28","author":"JC Marini","year":"2007","unstructured":"Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, Milgrom S, et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat. 2007;28:209\u201321. https:\/\/doi.org\/10.1002\/humu.20429.","journal-title":"Hum Mutat"},{"key":"825_CR6","doi-asserted-by":"crossref","unstructured":"Gentili C, Cancedda R. Cartilage and bone extracellular matrix. Curr Pharm Des. 2009;15:1334\u201348. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19355972. Accessed 13 Nov 2018.","DOI":"10.2174\/138161209787846739"},{"key":"825_CR7","doi-asserted-by":"crossref","unstructured":"Rauch F, Travers R, Parfitt a M, Glorieux FH. Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone. 2000;26:581\u20139.","DOI":"10.1016\/S8756-3282(00)00269-6"},{"key":"825_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00223-008-9113-x","volume":"82","author":"P Roschger","year":"2008","unstructured":"Roschger P, Fratzl-Zelman N, Misof BM, Glorieux FH, Klaushofer K, Rauch F. Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations. Calcif Tissue Int. 2008;82:263\u201370. https:\/\/doi.org\/10.1007\/s00223-008-9113-x.","journal-title":"Calcif Tissue Int"},{"key":"825_CR9","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1210\/jc.2016-1334","volume":"101","author":"N Fratzl-Zelman","year":"2016","unstructured":"Fratzl-Zelman N, Barnes AM, Weis M, Carter E, Hefferan TE, Perino G, et al. Non-lethal Type VIII osteogenesis imperfecta has elevated bone matrix mineralization. J Clin Endocrinol Metab. 2016;101:3516\u201325. https:\/\/doi.org\/10.1210\/jc.2016-1334.","journal-title":"J Clin Endocrinol Metab"},{"key":"825_CR10","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1136\/archdischild-2017-313859","volume":"103","author":"L Salter","year":"2018","unstructured":"Salter L, Offiah AC, Bishop N. Elevated platelet counts in a cohort of children with moderate-severe osteogenesis imperfecta suggest that inflammation is present. Arch Dis Child. 2018;103:767\u201371. https:\/\/doi.org\/10.1136\/archdischild-2017-313859.","journal-title":"Arch Dis Child"},{"key":"825_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2017.06.004","volume":"103","author":"BG Matthews","year":"2017","unstructured":"Matthews BG, Roeder E, Wang X, Aguila HL, Lee SK, Grcevic D, et al. Splenomegaly, myeloid lineage expansion and increased osteoclastogenesis in osteogenesis imperfecta murine. Bone. 2017;103:1\u201311.","journal-title":"Bone"},{"key":"825_CR12","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nm.3544","volume":"20","author":"I Grafe","year":"2014","unstructured":"Grafe I, Yang T, Alexander S, Homan EP, Lietman C, Jiang MM, et al. Excessive transforming growth factor-\u03b2 2 signaling is a common mechanism in osteogenesis imperfecta. Nat Med. 2014;20:670\u20135.","journal-title":"Nat Med"},{"key":"825_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.bone.2016.01.001","volume":"84","author":"BP Sinder","year":"2016","unstructured":"Sinder BP, Lloyd WR, Salemi JD, Marini JC, Caird MS, Morris MD, et al. Effect of anti-sclerostin therapy and osteogenesis imperfecta on tissue-level properties in growing and adult mice while controlling for tissue age. Bone. 2016;84:222\u20139. https:\/\/doi.org\/10.1016\/j.bone.2016.01.001.","journal-title":"Bone"},{"key":"825_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/jbmr.3617","volume":"34","author":"JT Tauer","year":"2019","unstructured":"Tauer JT, Abdullah S, Rauch F. Effect of anti-TGF-\u03b2 treatment in a mouse model of severe osteogenesis imperfecta. J Bone Miner Res. 2019;34:207\u201314. https:\/\/doi.org\/10.1002\/jbmr.3617.","journal-title":"J Bone Miner Res"},{"key":"825_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrg2484","volume":"10","author":"Z Wang","year":"2009","unstructured":"Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009;10:57\u201363. https:\/\/doi.org\/10.1038\/nrg2484.","journal-title":"Nat Rev Genet"},{"key":"825_CR16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ajhg.2019.01.012","volume":"104","author":"HD Gonorazky","year":"2019","unstructured":"Gonorazky HD, Naumenko S, Ramani AK, Nelakuditi V, Mashouri P, Wang P, et al. Expanding the boundaries of RNA sequencing as a diagnostic tool for rare Mendelian disease. Am J Hum Genet. 2019;104:466\u201383.","journal-title":"Am J Hum Genet"},{"key":"825_CR17","doi-asserted-by":"crossref","unstructured":"Auslander N, Ramos DM, Zelaya I, Karathia H, Sch\u00e4ffer AA, Crawford TO, et al. The GENDULF algorithm: mining transcriptomics to uncover modifier genes for monogenic diseases. SSRN Electron J. 2020.","DOI":"10.2139\/ssrn.3517533"},{"key":"825_CR18","doi-asserted-by":"publisher","unstructured":"Mears AJ, Schock SC, Hadwen J, Putos S, Dyment D, Boycott KM, et al. Mining the transcriptome for rare disease therapies: a comparison of the efficiencies of two data mining approaches and a targeted cell-based drug screen. npj Genomic Med. 2017;2:14. doi:https:\/\/doi.org\/10.1038\/s41525-017-0018-3.","DOI":"10.1038\/s41525-017-0018-3"},{"key":"825_CR19","doi-asserted-by":"publisher","unstructured":"Hadwen J, Schock S, Mears A, Yang R, Charron P, Zhang L, et al. Transcriptomic RNAseq drug screen in cerebrocortical cultures: toward novel neurogenetic disease therapies. doi:https:\/\/doi.org\/10.1093\/hmg\/ddy221.","DOI":"10.1093\/hmg\/ddy221"},{"key":"825_CR20","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s41591-019-0457-8","volume":"25","author":"L Fr\u00e9sard","year":"2019","unstructured":"Fr\u00e9sard L, Smail C, Ferraro NM, Teran NA, Li X, Smith KS, et al. Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts. Nat Med. 2019;25:911\u20139. https:\/\/doi.org\/10.1038\/s41591-019-0457-8.","journal-title":"Nat Med"},{"key":"825_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ebiom.2019.10.035","volume":"49","author":"M Hecker","year":"2019","unstructured":"Hecker M. Blood transcriptome profiling captures dysregulated pathways and response to treatment in neuroimmunological disease. EBioMedicine. 2019;49:2\u20133.","journal-title":"EBioMedicine"},{"key":"825_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.lab.2005.10.005","volume":"147","author":"C-C Liew","year":"2006","unstructured":"Liew C-C, Ma J, Tang H-C, Zheng R, Dempsey AA. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med. 2006;147:126\u201332. https:\/\/doi.org\/10.1016\/j.lab.2005.10.005.","journal-title":"J Lab Clin Med"},{"key":"825_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/1535370216679899","volume":"242","author":"K Maasalu","year":"2017","unstructured":"Maasalu K, Laius O, Zhytnik L, K\u00f5ks S, Prans E, Reimann E, et al. Featured article: transcriptional landscape analysis identifies differently expressed genes involved in follicle-stimulating hormone induced postmenopausal osteoporosis. Exp Biol Med. 2017;242:203\u201313. https:\/\/doi.org\/10.1177\/1535370216679899.","journal-title":"Exp Biol Med"},{"key":"825_CR24","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy DJ, Chen Y, Smyth GK. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012;40:4288\u201397. https:\/\/doi.org\/10.1093\/nar\/gks042.","journal-title":"Nucleic Acids Res"},{"key":"825_CR25","doi-asserted-by":"publisher","first-page":"e1005752","DOI":"10.1371\/journal.pcbi.1005752","volume":"13","author":"F Rohart","year":"2017","unstructured":"Rohart F, Gautier B, Singh A, L\u00ea Cao K-A. mixOmics: An R package for \u2018omics feature selection and multiple data integration. PLOS Comput Biol. 2017;13:e1005752. https:\/\/doi.org\/10.1371\/journal.pcbi.1005752.","journal-title":"PLOS Comput Biol"},{"key":"825_CR26","doi-asserted-by":"publisher","first-page":"W191","DOI":"10.1093\/nar\/gkz369","volume":"47","author":"U Raudvere","year":"2019","unstructured":"Raudvere U, Kolberg L, Kuzmin I, Arak T, Adler P, Peterson H, et al. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 2019;47:W191\u20138. https:\/\/doi.org\/10.1093\/nar\/gkz369.","journal-title":"Nucleic Acids Res"},{"key":"825_CR27","doi-asserted-by":"publisher","first-page":"D183","DOI":"10.1093\/nar\/gkw1138","volume":"45","author":"H Mi","year":"2017","unstructured":"Mi H, Huang X, Muruganujan A, Tang H, Mills C, Kang D, et al. PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements. Nucleic Acids Res. 2017;45:D183\u20139. https:\/\/doi.org\/10.1093\/nar\/gkw1138.","journal-title":"Nucleic Acids Res"},{"key":"825_CR28","doi-asserted-by":"publisher","unstructured":"Koumakis L, Roussos P, Potamias G. minepath.org: a free interactive pathway analysis web server. Nucleic Acids Res. 2017;45:W116\u201321. doi:https:\/\/doi.org\/10.1093\/nar\/gkx278.","DOI":"10.1093\/nar\/gkx278"},{"key":"825_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/boc.201600034","volume":"109","author":"H Gytz","year":"2017","unstructured":"Gytz H, Hansen MF, Skovbjerg S, Kristensen ACM, H\u00f8rlyck S, Jensen MB, et al. Apoptotic properties of the type 1 interferon induced family of human mitochondrial membrane ISG12 proteins. Biol Cell. 2017;109:94\u2013112. https:\/\/doi.org\/10.1111\/boc.201600034.","journal-title":"Biol Cell"},{"key":"825_CR30","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1161\/CIRCRESAHA.111.258814","volume":"110","author":"N Papac-Milicevic","year":"2012","unstructured":"Papac-Milicevic N, Breuss JM, Zaujec J, Ryban L, Plyushch T, Wagner GA, et al. The interferon stimulated gene 12 inactivates vasculoprotective functions of NR4A nuclear receptors. Circ Res. 2012;110:e50-63. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.258814.","journal-title":"Circ Res"},{"key":"825_CR31","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/j.1349-7006.2004.tb02189.x","volume":"95","author":"M Nishiu","year":"2004","unstructured":"Nishiu M, Tomita Y, Nakatsuka SI, Takakuwa T, Iizuka N, Hoshida Y, et al. Distinct pattern of gene expression in pyothorax-associated lymphoma (PAL), a lymphoma developing in long-standing inflammation. Cancer Sci. 2004;95:828\u201334. https:\/\/doi.org\/10.1111\/j.1349-7006.2004.tb02189.x.","journal-title":"Cancer Sci"},{"key":"825_CR32","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.0022-202X.2004.22322.x","volume":"122","author":"S Suomela","year":"2004","unstructured":"Suomela S, Cao L, Bowcock A, Saarialho-Kere U. Interferon \u03b1-inducible protein 27 (IFI27) is upregulated in psoriatic skin and certain epithelial cancers. J Invest Dermatol. 2004;122:717\u201321. https:\/\/doi.org\/10.1111\/j.0022-202X.2004.22322.x.","journal-title":"J Invest Dermatol"},{"key":"825_CR33","doi-asserted-by":"publisher","first-page":"16943","DOI":"10.3390\/ijms140816943","volume":"14","author":"CP Hsiao","year":"2013","unstructured":"Hsiao CP, Araneta M, Wang XM, Saligan LN. The association of IFI27 expression and fatigue intensification during localized radiation therapy: implication of a para-inflammatory bystander response. Int J Mol Sci. 2013;14:16943\u201357.","journal-title":"Int J Mol Sci"},{"key":"825_CR34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol. 2005;5:375\u201386.","journal-title":"Nat Rev Immunol"},{"key":"825_CR35","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1053\/jhep.2003.50408","volume":"38","author":"Y Inagaki","year":"2003","unstructured":"Inagaki Y, Nemoto T, Kushida M, Sheng Y, Higashi K, Ikeda K, et al. Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice. Hepatology. 2003;38:890\u20139. https:\/\/doi.org\/10.1053\/jhep.2003.50408.","journal-title":"Hepatology"},{"key":"825_CR36","doi-asserted-by":"publisher","first-page":"16009","DOI":"10.1038\/boneres.2016.9","volume":"4","author":"M Wu","year":"2016","unstructured":"Wu M, Chen G, Li YP. TGF-\u03b2 and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res. 2016;4:16009.","journal-title":"Bone Res"},{"key":"825_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40001-014-0074-4","volume":"20","author":"C Seeliger","year":"2015","unstructured":"Seeliger C, Schyschka L, Kronbach Z, Wottge A, van Griensven M, Wildemann B, et al. Signaling pathway STAT1 is strongly activated by IFN-\u03b2 in the pathogenesis of osteoporosis. Eur J Med Res. 2015;20:1. https:\/\/doi.org\/10.1186\/s40001-014-0074-4.","journal-title":"Eur J Med Res"},{"key":"825_CR38","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1172\/JCI111480","volume":"74","author":"SA Jimenez","year":"1984","unstructured":"Jimenez SA, Freundlich B, Rosenbloom J. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest. 1984;74:1112\u20136. https:\/\/doi.org\/10.1172\/JCI111480.","journal-title":"J Clin Invest"},{"key":"825_CR39","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1084\/jem.162.2.516","volume":"162","author":"MR Duncan","year":"1985","unstructured":"Duncan MR, Berman B. \u03b3 interferon is the lymphokine and \u03b2 interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med. 1985;162:516\u201327. https:\/\/doi.org\/10.1084\/jem.162.2.516.","journal-title":"J Exp Med"},{"key":"825_CR40","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1172\/JCI30074","volume":"117","author":"Y Gao","year":"2007","unstructured":"Gao Y, Grassi F, Ryan MR, Terauchi M, Page K, Yang X, et al. IFN-\u03b3 stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest. 2007;117:122\u201332. https:\/\/doi.org\/10.1172\/JCI30074.","journal-title":"J Clin Invest"},{"key":"825_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1471-2164-13-155","volume":"13","author":"D Hickford","year":"2012","unstructured":"Hickford D, Frankenberg S, Shaw G, Renfree MB. Evolution of vertebrate interferon inducible transmembrane proteins. BMC Genom. 2012;13:155.","journal-title":"BMC Genom"},{"key":"825_CR42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ajhg.2012.06.011","volume":"91","author":"O Semler","year":"2012","unstructured":"Semler O, Garbes L, Keupp K, Swan D, Zimmermann K, Becker J, et al. A mutation in the 5\u2032-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus. Am J Hum Genet. 2012;91:349\u201357. https:\/\/doi.org\/10.1016\/j.ajhg.2012.06.011.","journal-title":"Am J Hum Genet"},{"key":"825_CR43","doi-asserted-by":"publisher","unstructured":"Lim JY, Bhatia N, Vasanwala RF, Chay PL, Lim KBL, Khoo PC, et al. A novel Ser40Trp variant in IFITM5 in a family with osteogenesis imperfecta and review of the literature. Clin Dysmorphol. 2019;:1. doi:https:\/\/doi.org\/10.1097\/MCD.0000000000000279.","DOI":"10.1097\/MCD.0000000000000279"},{"key":"825_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-1236-z","volume":"10","author":"X Liu","year":"2019","unstructured":"Liu X, Chen L, Fan Y, Hong Y, Yang X, Li Y, et al. IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-\u03b2 signaling pathway. Cell Death Dis. 2019;10:1\u201316.","journal-title":"Cell Death Dis"},{"key":"825_CR45","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1128\/MCB.00272-08","volume":"28","author":"UC Lange","year":"2008","unstructured":"Lange UC, Adams DJ, Lee C, Barton S, Schneider R, Bradley A, et al. Normal germ line establishment in mice carrying a deletion of the Ifitm\/Fragilis gene family cluster. Mol Cell Biol. 2008;28:4688\u201396. https:\/\/doi.org\/10.1128\/MCB.00272-08.","journal-title":"Mol Cell Biol"},{"key":"825_CR46","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/cr.2010.143","volume":"21","author":"G Paratcha","year":"2011","unstructured":"Paratcha G, Ledda F. The GTPase-activating protein Rap1GAP: a new player to modulate Ret signaling. Cell Res. 2011;21:217\u20139.","journal-title":"Cell Res"},{"key":"825_CR47","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s11596-011-0667-x","volume":"31","author":"W Li","year":"2011","unstructured":"Li W, Jin B, Cornelius LA, Zhou B, Fu X, Shang D, et al. Inhibitory effects of Rap1GAP overexpression on proliferation and migration of endothelial cells via ERK and Akt pathways. J Huazhong Univ Sci Technol - Med Sci. 2011;31:721\u20137. https:\/\/doi.org\/10.1007\/s11596-011-0667-x.","journal-title":"J Huazhong Univ Sci Technol - Med Sci"},{"key":"825_CR48","doi-asserted-by":"publisher","unstructured":"Dubail J, Brunelle P, Baujat G, Huber C, Doyard M, Michot C, et al. Homozygous loss\u2010of\u2010function mutations in CCDC134 are responsible for a severe form of osteogenesis imperfecta. J Bone Miner Res. 2020;:jbmr.4011. doi:https:\/\/doi.org\/10.1002\/jbmr.4011.","DOI":"10.1002\/jbmr.4011"},{"key":"825_CR49","doi-asserted-by":"crossref","unstructured":"Lu N, Malemud CJ. Extracellular signal-regulated kinase: a regulator of cell growth, inflammation, chondrocyte and bone cell receptor-mediated gene expression. International Journal of Molecular Sciences. 2019;20.","DOI":"10.3390\/ijms20153792"},{"key":"825_CR50","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.bone.2010.01.166","volume":"46","author":"A Blais","year":"2010","unstructured":"Blais A, Malet A, Mikogami T, Tom\u00e9 D. Bovine Lactoferrin improves bone status of ovariectomized mice via immune function modulation. Bone. 2010;46:S69.","journal-title":"Bone"},{"key":"825_CR51","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3121\/cmr.3.2.93","volume":"3","author":"D Naot","year":"2005","unstructured":"Naot D, Grey A, Reid IR, Cornish J. Lactoferrin\u2013a novel bone growth factor. Clin Med Res. 2005;3:93\u2013101.","journal-title":"Clin Med Res"},{"key":"825_CR52","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1210\/en.2003-1307","volume":"145","author":"J Cornish","year":"2004","unstructured":"Cornish J, Callon KE, Naot D, Palmano KP, Banovic T, Bava U, et al. Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology. 2004;145:4366\u201374. https:\/\/doi.org\/10.1210\/en.2003-1307.","journal-title":"Endocrinology"},{"key":"825_CR53","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/aps.2012.83","volume":"33","author":"JM Hou","year":"2012","unstructured":"Hou JM, Xue Y, Lin QM. Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG\/RANKL\/RANK pathway. Acta Pharmacol Sin. 2012;33:1277\u201384.","journal-title":"Acta Pharmacol Sin"},{"key":"825_CR54","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1007\/s11999-015-4270-5","volume":"473","author":"W Li","year":"2015","unstructured":"Li W, Zhu S, Hu J. Bone regeneration is promoted by orally administered bovine lactoferrin in a rabbit tibial distraction osteogenesis model. Clin Orthop Relat Res. 2015;473:2383\u201393. https:\/\/doi.org\/10.1007\/s11999-015-4270-5.","journal-title":"Clin Orthop Relat Res"},{"key":"825_CR55","doi-asserted-by":"publisher","first-page":"37024","DOI":"10.1074\/jbc.M300191200","volume":"278","author":"A Caricasole","year":"2003","unstructured":"Caricasole A, Ferraro T, Iacovelli L, Barletta E, Caruso A, Melchiorri D, et al. Functional characterization of WNT7A signaling in PC12 cells: Interaction with a FZD5-LRP6 receptor complex and modulation by Dickkopf proteins. J Biol Chem. 2003;278:37024\u201331. https:\/\/doi.org\/10.1074\/jbc.M300191200.","journal-title":"J Biol Chem"},{"key":"825_CR56","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1359\/jbmr.060819","volume":"21","author":"H Aslan","year":"2006","unstructured":"Aslan H, Ravid-Amir O, Clancy BM, Rezvankhah S, Pittman D, Pelled G, et al. Advanced molecular profiling in vivo detects novel function of dickkopf-3 in the regulation of bone formation. J Bone Miner Res. 2006;21:1935\u201345. https:\/\/doi.org\/10.1359\/jbmr.060819.","journal-title":"J Bone Miner Res"},{"key":"825_CR57","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ajhg.2013.02.010","volume":"92","author":"K Keupp","year":"2013","unstructured":"Keupp K, Beleggia F, Kayserili H, Barnes AM, Steiner M, Semler O, et al. Mutations in WNT1 cause different forms of bone fragility. Am J Hum Genet. 2013;92:565\u201374. https:\/\/doi.org\/10.1016\/j.ajhg.2013.02.010.","journal-title":"Am J Hum Genet"},{"key":"825_CR58","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/bonekey.2015.143","volume":"5","author":"A Costantini","year":"2016","unstructured":"Costantini A, M\u00e4kitie O. Value of rare low bone mass diseases for osteoporosis genetics. Bonekey Rep. 2016;5:773. https:\/\/doi.org\/10.1038\/bonekey.2015.143.","journal-title":"Bonekey Rep"},{"key":"825_CR59","doi-asserted-by":"publisher","first-page":"e10171","DOI":"10.1002\/jbm4.10171","volume":"3","author":"SM Zimmerman","year":"2019","unstructured":"Zimmerman SM, Dimori M, Heard-Lipsmeyer ME, Morello R. The Osteocyte transcriptome is extensively dysregulated in mouse models of osteogenesis imperfecta. JBMR Plus. 2019;3:e10171. https:\/\/doi.org\/10.1002\/jbm4.10171.","journal-title":"JBMR Plus"},{"key":"825_CR60","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1203\/00006450-198303000-00007","volume":"17","author":"R Baron","year":"1983","unstructured":"Baron R, Gertner JM, Lang R, Vignery A. Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda. Pediatr Res. 1983;17:204\u20137. https:\/\/doi.org\/10.1203\/00006450-198303000-00007.","journal-title":"Pediatr Res"},{"key":"825_CR61","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/s0945-053x(97)90025-1","volume":"15","author":"G Murphy","year":"1997","unstructured":"Murphy G, Kn\u00e4uper V. Relating matrix metalloproteinase structure to function: why the \u201chemopexin\u201d domain? Matrix Biol. 1997;15:511\u20138. https:\/\/doi.org\/10.1016\/s0945-053x(97)90025-1.","journal-title":"Matrix Biol"},{"key":"825_CR62","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1172\/JCI10158","volume":"106","author":"W Zhao","year":"2000","unstructured":"Zhao W, Byrne MH, Wang Y, Krane SM. Osteocyte and osteoblast apoptosis and excessive bone deposition accompany failure of collagenase cleavage of collagen. J Clin Invest. 2000;106:941\u20139.","journal-title":"J Clin Invest"},{"key":"825_CR63","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00223-019-00547-8","volume":"104","author":"SK Bhadada","year":"2019","unstructured":"Bhadada SK, Dhaliwal R, Dhiman V, Rao SD. Fibrogenesis imperfecta ossium. Calcif Tissue Int. 2019;104:561\u20139.","journal-title":"Calcif Tissue Int"},{"key":"825_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/boneres.2016.57","volume":"5","author":"ML Barron","year":"2017","unstructured":"Barron ML, Rybchyn MS, Ramesh S, Mason RS, Fiona Bonar S, Stalley P, et al. Clinical, cellular, microscopic, and ultrastructural studies of a case of fibrogenesis imperfecta ossium. Bone Res. 2017;5:1\u201314.","journal-title":"Bone Res"},{"key":"825_CR65","doi-asserted-by":"crossref","unstructured":"Meena B, Panigrahi I, Marwaha R. PO-0077 Vitamin D deficiency in children with osteogenesis imperfecta. Arch Dis Child. 2014;99 Suppl 2:A275.1-A275.","DOI":"10.1136\/archdischild-2014-307384.747"},{"key":"825_CR66","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1210\/jc.2011-1480","volume":"96","author":"T Edouard","year":"2011","unstructured":"Edouard T, Glorieux FH, Rauch F. Predictors and correlates of vitamin D status in children and adolescents with osteogenesis imperfecta. J Clin Endocrinol Metab. 2011;96:3193\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"825_CR67","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/jcb.22010","volume":"106","author":"L Shen","year":"2009","unstructured":"Shen L, Zhou S, Glowacki J. Effects of age and gender on WNT gene expression in human bone marrow stromal cells. J Cell Biochem. 2009;106:337\u201343. https:\/\/doi.org\/10.1002\/jcb.22010.","journal-title":"J Cell Biochem"},{"key":"825_CR68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jss.2009.03.095","volume":"160","author":"LK Ehrlichman","year":"2010","unstructured":"Ehrlichman LK, Ford JW, Roelofs KJ, Tedeschi-Filho W, Futchko JS, Ramacciotti E, et al. Gender-dependent differential phosphorylation in the ERK signaling pathway is associated with increased MMP2 activity in rat aortic smooth muscle cells. J Surg Res. 2010;160:18\u201324. https:\/\/doi.org\/10.1016\/j.jss.2009.03.095.","journal-title":"J Surg Res"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-020-00825-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12920-020-00825-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-020-00825-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T20:17:57Z","timestamp":1606162677000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-020-00825-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["825"],"URL":"https:\/\/doi.org\/10.1186\/s12920-020-00825-7","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,23]]},"assertion":[{"value":"12 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed written consent was collected from all subjects and controls, or their legal representatives, prior to inclusion in the study and collection of their clinical information and biological samples. A written informed consent to participate in the study was also obtained from parents or legal guardians of participants under the age of 16. The study was conducted in accordance with the Helsinki Declaration and authorized by the Ethical Review Committee on Human Research of the University of Tartu (Permit No. 221\/M-34).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A written informed consent for publication was obtained from the participants and parents or legal guardians of any participant under the age of 18. No identifying images or identifying personal details of participants are included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"177"}}